IBEX Ltd director plans sale of 5,000 shares

The shares are listed as acquired from IBEX through an RSA vest on December 28, 2018.

Rhea-AI Filing Summary

IBEX Ltd officer and director Robert Thomas Dechant reports 5,000 common shares for sale, with an aggregate market value of $225,095.00 and an approximate sale date of September 25, 2026. RBC Capital Markets LLC is listed as the broker, and NASDAQ is listed as the exchange. Remarks state that the sale is pursuant to a Rule 10b5-1 plan established November 18, 2025.

Key Figures

Common shares for sale: 5,000 shares Aggregate market value: $225,095.00 Shares outstanding: 13,389,116 shares +1 more

4 metrics

Common shares for sale 5,000 shares Approximate sale date: September 25, 2026

Aggregate market value $225,095.00 Shares listed for sale

Shares outstanding 13,389,116 shares Figure shown in the securities information

Rule 10b5-1 plan established November 18, 2025 Plan associated with the sale

Key Terms

Rule 10b5-1 plan, RSA VEST, Rule 144

3 terms

Rule 10b5-1 plan regulatory

"pursuant to a Rule 10b5-1 plan established 11/18/2025"

A Rule 10b5-1 plan is a prearranged, written schedule that lets corporate insiders buy or sell company stock at set times or amounts, even if they later learn material nonpublic information. Think of it like setting an automatic thermostat for trades: it creates a clear record that trades were planned in advance, reducing the risk of insider-trading accusations and helping investors trust that insider transactions are routine rather than based on secret information.

RSA VEST financial

"12/28/2018 | RSA VEST | ISSUER"

Rule 144 regulatory

"sales required by paragraph (e) of Rule 144"

Rule 144 is a U.S. securities regulation that sets conditions under which restricted or insider-held shares can be legally resold to the public, such as required holding periods, availability of public information, limits on how much can be sold at once, and certain filing requirements. For investors it matters because it determines when previously locked-up shares can enter the market — like a release valve that can increase supply, affect share price, and signal insider intent.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

How many IBEX shares is Robert Thomas Dechant reporting for sale?

Robert Thomas Dechant is reporting 5,000 common shares for sale, with an aggregate market value of $225,095.00 and an approximate sale date of September 25, 2026.

When did Dechant acquire the IBEX shares listed for sale?

The 5,000 shares are listed as acquired from the issuer through an RSA vest on December 28, 2018.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 09/25/2026 - 04:37 PM Accepted by SEC EDGAR 09/25/2026 - 04:20 PM Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001298255
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	IBEX Ltd
SEC File Number	001-38442
Address of Issuer	1717 PENNSYLVANIA AVENUE NW SUITE 825 WASHINGTON DISTRICT OF COLUMBIA 20006
Phone	(202)580-6200
Name of Person for Whose Account the Securities are To Be Sold	Dechant Robert Thomas
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Officer
Relationship to Issuer	Director

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
COMMON	RBC CAPITAL MARKETS LLC 250 NICOLLET MALL SUITE 1700 MINNEAPOLIS MN 55401	5000	225095.00	13389116	09/25/2026	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
COMMON	12/28/2018	RSA VEST	ISSUER			5000	12/28/2018	N/A

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks	SOLD PURSUANT TO A RULE 10B5-1 PLAN ESTABLISHED 11/18/2025
Date of Notice	09/25/2026
Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1	11/18/2025
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	POA JEFF KAPALA
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)